BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.880
-0.010 (-0.53%)
At close: Oct 24, 2025, 4:00 PM EDT
1.860
-0.020 (-1.06%)
After-hours: Oct 24, 2025, 7:22 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $14.17 million as of October 24, 2025. Its market cap has increased by 47.61% in one year.
Market Cap
14.17M
Enterprise Value
-3.02M
1-Year Change
47.61%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $14.17M, a decrease of -72.75%. That is a compound annual growth rate of -22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 14.20M | -60.00% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |